Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- MIST
- Price
- 1.69
- Stock movement up
- +0.07 (4.27%)
- Company name
- Milestone Pharmaceuticals Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 145.34M
- Ent value
- 191.24M
- Price/Sales
- -
- Price/Book
- 6.05
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 7.22%
- 1 year return
- 25.74%
- 3 year return
- -37.07%
- 5 year return
- -27.52%
- 10 year return
- -
Last updated: 2025-09-15
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
MIST does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 6.05 |
| EV to Sales | -110.16 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 84.99M |
| EPS (TTM) | -0.65 |
| FCF per share (TTM) | -0.47 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | -1.74M |
| Gross profit (TTM) | -1.45M |
| Operating income (TTM) | -43.70M |
| Net income (TTM) | -42.77M |
| EPS (TTM) | -0.65 |
| EPS (1y forward) | -1.03 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 83.76% |
| Operating margin (TTM) | 2517.04% |
| Profit margin (TTM) | 2463.53% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 12.80M |
| Net receivables | 2.05M |
| Total current assets | 80.99M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 1.72M |
| Total assets | 82.71M |
| Accounts payable | 1.63M |
| Short/Current long term debt | 54.02M |
| Total current liabilities | 5.26M |
| Total liabilities | 58.69M |
| Shareholder's equity | 24.01M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -31.23M |
| Capital expenditures (TTM) | 70.29K |
| Free cash flow (TTM) | -31.27M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -178.11% |
| Return on Assets | -51.71% |
| Return on Invested Capital | -55.52% |
| Cash Return on Invested Capital | -40.59% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 1.67 |
| Daily high | 1.75 |
| Daily low | 1.63 |
| Daily Volume | 1.58M |
| All-time high | 27.15 |
| 1y analyst estimate | 3.33 |
| Beta | 0.52 |
| EPS (TTM) | -0.65 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 12 Nov 2025 |
Downside potential
Loading...
Downside potential data
| MIST | S&P500 | |
| Current price drop from All-time high | -93.70% | -1.46% |
| Highest price drop | -97.60% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -76.39% | -10.99% |
| Avg time to new high | 113 days | 12 days |
| Max time to new high | 1546 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
145.34M
Marketcap category
Small-cap
Description
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. The company's lead product candidate is etripamil, a novel and potent calcium channel blocker, which has completed phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.
Employees
33
Investor relations
-
SEC filings
CEO
Joseph G. Oliveto
Country
USA
City
Montréal
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page